Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis

By Samara Katerina D.   Antoniou Katerina M.   Karagiannis Konstantinos   Margaritopoulos Georgios   Lasithiotaki Ismini   Koutala Eleni   Siafakas Nikolaos M.  

International Journal of Oncology, Vol. 40, Iss. 5, 2012-05 ,pp. : 1397-1404

Spandidos Publications

Access to resources Recommend Favorite

Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment

By Maas K.W.   van der Lee I.   Bolt K.   Zanen P.   Lammers J.W.J.   Schramel F.M.N.H.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 345-351

Elsevier

Access to resources Recommend Favorite

Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway

By            

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 651-658

Spandidos Publications

Access to resources Recommend Favorite

Effects of Gemcitabine on renal function in patients with non-small cell lung cancer

By Gietema J.A.   Groen H.J.M.   Meijer S.   Smit E.F.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

Quantitative study of lung perfusion SPECT scanning and pulmonary function testing for early radiation-induced lung injury in patients with locally advanced non-small cell lung cancer

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 4, 2012-01 ,pp. : 631-635

Spandidos Publications

Access to resources Recommend Favorite